What are the complications of interventional therapy for liver cancer

summary

Some time ago, the father of one of my colleagues got liver cancer. He was often weak and had liver pain. He was treated in the hospital for a period of time. Later, I heard that there is a good treatment for liver cancer, which is interventional therapy. Because we have never heard of this before, we don't know what harm it has. Now I will summarize the complications of interventional therapy for liver cancer.

What are the complications of interventional therapy for liver cancer

First: liver cancer is one of the common malignant tumors in China. Due to the clinical application of serum alpha fetoprotein (AFP) and the progress of various imaging technologies, especially the AFP and ultrasound imaging used for monitoring high-risk groups of liver cancer, liver cancer can be diagnosed in the subclinical stage without symptoms and signs. In addition, the mature surgical technology, and various non-surgical treatment methods such as local treatment, etc As a result, the prognosis of HCC has been significantly improved.

Second: the common complications of interventional therapy for liver cancer include cholecystitis, gastrointestinal mucosal erosion and ulcer, splenic embolism, esophageal variceal bleeding, etc. the rare complications include liver abscess, false thrombosis of non target organs, inflammation, etc. It is safe to use lipiodol emulsion and gelatin sponge in interventional treatment of liver cancer. As long as the application is appropriate, there is rarely infarction and necrosis of non target organs. Once it occurs, surgical treatment is needed. Reasonable nursing should be given to patients after operation to avoid and reduce adverse reactions and ensure the therapeutic effect of transcatheter arterial chemoembolization.

Third: there are two possible causes of gastrointestinal bleeding after interventional therapy for liver cancer: acute gastric mucosal damage: gastrointestinal bleeding caused by embolic material flowing back into the gastroduodenal artery or direct damage to the mucosa caused by chemotherapeutic drugs. Portal hypertension: after chemoembolization, it can lead to further aggravation of liver cirrhosis, increase of portal pressure, and induce esophageal and gastric variceal bleeding.

matters needing attention

Interventional therapy for liver cancer is also a double-edged sword. At the same time of treatment, there will be many complications, so we should prevent these complications in advance. In the process of treatment, once these complications are found, we should communicate with doctors in time to control the disease and not delay the best treatment time.